Address
Avon House
Penarth, CF64 2EZ
United Kingdom of Great Britain and Northern Ireland (the)
Phone
44 207 9338780
Website
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Employees
19
First IPO Date
November 03, 2020
| Name | Title | Pay | Year Born |
| Sara jane Barrington | Chief Executive Officer & Executive Director | 289,797 | 1967 |
| Keith Gilliard | Senior Director of Sales | 0 | N/A |
| David Anderson | Chief Financial Officer & Company Secretary | 0 | 1963 |
Verici Dx plc is an immuno-diagnostics company primarily focused on the kidney transplantation sector. The firm specializes in creating both predictive and diagnostic assays for patients who have undergone kidney transplants. Its development pipeline features Clarava, a pre-transplant tool designed to forecast the likelihood of early acute rejection; Tuteva, a post-transplant assessment focusing on acute cellular rejection; and Protega, an innovative liquid biopsy aiming to predict the risk of fibrosis and eventual graft failure. Established in 2020, Verici Dx plc maintains its headquarters in Penarth, United Kingdom.